1. Home
  2. MDV vs VYGR Comparison

MDV vs VYGR Comparison

Compare MDV & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$17.24

Market Cap

187.5M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.05

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
VYGR
Founded
2015
2013
Country
United States
United States
Employees
9
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.5M
203.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MDV
VYGR
Price
$17.24
$3.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$18.00
$16.50
AVG Volume (30 Days)
51.5K
737.1K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
7.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
N/A
$34.04
Revenue Next Year
$8.56
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.80
$2.88
52 Week High
$18.96
$5.55

Technical Indicators

Market Signals
Indicator
MDV
VYGR
Relative Strength Index (RSI) 42.12 38.00
Support Level $13.95 $2.96
Resistance Level $18.82 $4.33
Average True Range (ATR) 0.44 0.17
MACD -0.06 -0.00
Stochastic Oscillator 9.80 13.16

Price Performance

Historical Comparison
MDV
VYGR

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in, and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from the company's consolidated real estate properties.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: